Product NewsReprise prochaine du recrutement dans l'étude internationale de phase III AVANT sur le traitement adjuvant postopératoire du cancer du côlon
Product NewsColder Products Company Introduces Subminiature Couplings with IdentiQuik® RFID Technology
Product NewsOxford Biomedica reports new encouraging phase II results with TroVax® and progress in the development plan
Product NewsTopoTarget and CuraGen Initiate NCI-sponsored Phase II Clinical Trial of PXD101 for Acute Myelogenous Leukemia
Product NewsAXIS-SHIELD ANNOUNCES LAUNCH OF FIRST ASSAY UNDER AXSYM® XTRA PROGRAMME – PART OF PROJECT TO EXPAND AXSYM’S BROAD TEST MENU
Product NewsCeNeS announces the publication of an important independent review of its lead product, M6G
Product NewsGuava Technologies Announces FDA 510(k) Clearance of Guava® EZCD4 System for CD4 Monitoring
Product NewsGuava Technologies Announces FDA 510(k) Clearance of Guava® EZCD4 System for CD4 Monitoring
Product NewsSalisbury District Hospital goes live with Acolyte Biomedica’s BacLite®flex system for rapid MRSA screening
Product NewsOxford Biomedica secures agreement with FDA on special protocol assessment for phase III trial of TroVax in renal cancer
Product NewsBioAlliance Pharma starts pivotal Phase III clinical trial in the US of Loramyc® treatment for oropharyngeal candidiasis
Product NewsBioAlliance Pharma démarre une étude clinique pivot de phase III aux Etats-Unis pour le Loramyc® dans le traitement de la candidose oropharyngée
